Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nahid Ali

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Plos Pathogens|February 25, 2021
Super enhancer-mediated transcription of miR146a-5p drives M2 polarization during Leishmania donovani infectionSonali Das, Sohitri Mukherjee, Nahid Ali
Frontiers in Cellular and Infection Microbiology|December 20, 2021
HO-3867 Induces ROS-Dependent Stress Response and Apoptotic Cell Death in <i>Leishmania donovani</i>Amrita Das, Mohd Kamran, Nahid Ali
The Journal of Antimicrobial Chemotherapy|October 30, 2007
Stearylamine-bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserineAntara Banerjee, Jayeeta Roychoudhury, Nahid Ali
Expert Review of Anti-Infective Therapy|August 11, 2010
Current diagnosis and treatment of visceral leishmaniasisSmriti Mondal, Pradyot Bhattacharya, Nahid Ali
Plos One|March 23, 2011
Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c miceJayeeta Roychoudhury, Roma Sinha, Nahid Ali
Antimicrobial Agents and Chemotherapy|August 26, 2004
Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c MiceSwati Pal, Rajesh Ravindran, Nahid Ali
Cellular Immunology|July 30, 2016
Lipid based delivery and immuno-stimulatory systems: Master tools to combat leishmaniasisAbdus Sabur, Mohammad Asad, Nahid Ali
Vaccine|July 28, 2007
Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 responseSudipta Bhowmick, Rajesh Ravindran, Nahid Ali
Infection and Immunity|January 27, 2009
Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infectionSudipta Bhowmick, Tuhina Mazumdar, Nahid Ali
Molecular Pharmaceutics|December 3, 2011
Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable routeRajesh Ravindran, Mithun Maji, Nahid Ali
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Plos Pathogens|February 25, 2021
Super enhancer-mediated transcription of miR146a-5p drives M2 polarization during Leishmania donovani infectionSonali Das, Sohitri Mukherjee, Nahid Ali
Frontiers in Cellular and Infection Microbiology|December 20, 2021
HO-3867 Induces ROS-Dependent Stress Response and Apoptotic Cell Death in <i>Leishmania donovani</i>Amrita Das, Mohd Kamran, Nahid Ali
The Journal of Antimicrobial Chemotherapy|October 30, 2007
Stearylamine-bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserineAntara Banerjee, Jayeeta Roychoudhury, Nahid Ali
Expert Review of Anti-Infective Therapy|August 11, 2010
Current diagnosis and treatment of visceral leishmaniasisSmriti Mondal, Pradyot Bhattacharya, Nahid Ali
Plos One|March 23, 2011
Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c miceJayeeta Roychoudhury, Roma Sinha, Nahid Ali
Antimicrobial Agents and Chemotherapy|August 26, 2004
Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c MiceSwati Pal, Rajesh Ravindran, Nahid Ali
Cellular Immunology|July 30, 2016
Lipid based delivery and immuno-stimulatory systems: Master tools to combat leishmaniasisAbdus Sabur, Mohammad Asad, Nahid Ali
Vaccine|July 28, 2007
Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 responseSudipta Bhowmick, Rajesh Ravindran, Nahid Ali
Infection and Immunity|January 27, 2009
Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infectionSudipta Bhowmick, Tuhina Mazumdar, Nahid Ali
Molecular Pharmaceutics|December 3, 2011
Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable routeRajesh Ravindran, Mithun Maji, Nahid Ali
Pageof 11